Novartis, Google and Stevanato all contributed to a series C round for the biotherapeutics company, which has also signed a collaboration deal with Novartis.
US-based biotherapeutics company Rani Therapeutics raised an undisclosed amount on Tuesday in a series C round featuring pharmaceutical company Novartis, internet company Google and pharmaceutical packaging producer Stevanato.
The round also included InCube Ventures, the life sciences venture fund of research facility InCube Labs, and healthcare crowdfunding platform VentureHealth, as well as Crystal Horizon Investments, Pinemount Investments, Pacific Venture Opportunity Fund and Buttonwood Funds.
Rani, which was spun out of InCube Labs in 2012, has developed a process to convert…
